| Peer-Reviewed

Comparison of Pregnancy Outcomes in Thyroid Antibody-Positive Women with Different Fertilization Methods

Received: 2 September 2022    Accepted: 24 March 2023    Published: 11 April 2023
Views:       Downloads:
Abstract

Objective To compare the pregnancy outcomes of thyroid antibody (ATA) positive women treated by different fertilization methods during in vitro fertilization-embryo transfer. Methods A total of 204 female patients with normal thyroid function and positive ATA in the reproductive Medicine Center of the First Hospital of Shanxi Medical University from January 2020 to January 2022 were selected. According to different fertilization methods, they were divided into IVF group and ICSI group, including 115 IVF cycles and 89 ICSI cycles. The general data, clinical indicators after ovulation induction, fertilization, embryo status, and pregnancy outcome of the two groups were compared. Results There were no significant differences in age, BMI, bE2, FSH, FT3, FT4, AFC, Gn dosage, Gn stimulation time, E2 on HCG day, P on HCG day, intrauterine thickness on HCG day, number of retrieved oocytes and average number of embryos transferred between the two groups (P>0.05). The fertilization rate of the ICSI group was higher than that of IVF group within the group, while the high-quality embryo rate was significantly lower than that of the IVF group, with statistical significance (P<0.05). There were significant differences in sperm motility and sperm density between the two groups (P<0.05), and there was no significant difference between sperm volume and normal morphology rate (P>0.05). There were no significant differences in embryo implantation rate, biochemical pregnancy rate, clinical pregnancy rate, early abortion rate and live birth rate between the two groups (P>0.05). Logistic regression analysis showed that the method of assisted pregnancy and semen quality were not independent factors affecting high-quality embryo (P>0.05). In IVF group, TGAb was negatively correlated with fertilization rate (r=-0.202, P<0.05); and in ICSI group, TPOAb was negatively correlated with high quality embryo rate (r=-0.349, P<0.05). Conclusion Thyroid autoimmunity (TAI) in infertile women undergoing assisted reproductive technology (ART), the semen quality should be considered as the priority criteria for ATA. ICSI should not be recommended as routine fertilization.

Published in Biomedical Sciences (Volume 9, Issue 2)
DOI 10.11648/j.bs.20230902.11
Page(s) 35-41
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2023. Published by Science Publishing Group

Keywords

Thyroid Antibodies, Thyroid Autoimmunity, Different Fertilization Methods, Pregnancy Outcomes

References
[1] Der A, Dumestre-Perard C, Dunand-Faure C, et al. Female Infertility and Serum Auto-antibodies: a Systematic Review [J]. Clin Rev Allerg Immu, 2017, 53 (1): 78-86.
[2] The Fourth Committee of the Reproductive Medicine Branch of the Chinese Medical Association. Chinese expert consensus on the diagnosis and management of subclinical hypothyroidism in infertile women [J]. Chinese Journal of Reproduction and Contraception, 2019, 39 (8): 609-621.
[3] Pedersen IB, Laurberg P, Knudsen N, et al. Lack of association between thyroid autoantibodies and parity in a population study argues against microchimerism as a trigger of thyroid autoimmunity [J]. Eur J Endocrinol, 2006, 154 (1): 39-45.
[4] Poppe K, Velkeniers B, Glinoer D. The role of thyroid autoimmunity in fertility and pregnancy [J]. Nat Clin Pract Endoc M, 2008.
[5] Hollowell JG, Staehling NW, Dana FW, et al. Serum TSH, T (4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III) [J]. J Clin Endoc M, 2002, (2): 489.
[6] Korevaar T, Derakhshan A, Taylor PN, et al. Association of Thyroid Function Test Abnormalities and Thyroid Autoimmunity With Preterm Birth: A Systematic Review and Meta-analysis [J]. Obstet Gynecol Surv, 2020, 75 (1): 10-12.
[7] Esteves SC, Humaidan P, Roque M, et al. Female infertility and assisted reproductive technology [J]. Panminerva Medica, 2019, 61 (1).
[8] Berntsen S, Nøhr B, Grøndahl M, et al. In vitro fertilization (IVF) versus intracytoplasmic sperm injection (ICSI) in patients without severe male factor infertility: study protocol for the randomized, controlled, multicentre trial INVICSI [J]. BMJ open, 2021, 11 (6): e051058.
[9] Matalliotakis I, Cakmak H, Sakkas D, et al. Impact of body mass index on IVF and ICSI outcome: a retrospective study [J]. Reprod Biomed Online, 2008, 16 (6): 778-783.
[10] Poppe K, Autin C, Veltri F, et al. Thyroid Autoimmunity and Intracytoplasmic Sperm Injection Outcome: A Systematic Review and Meta-Analysis [J]. J Clin Endocrinol M, 2018, 103 (5): 1755-1766.
[11] Safarian G K, Gzgzyan A M, Dzhemlikhanova Lyailya K, et al. Does subclinical hypothyroidism and/or thyroid autoimmunity influence the IVF/ICSI outcome? Review of the literature [J]. Gynecol Endocrinol, 2019, 35 (sup1): 56-59.
[12] Guidelines for the diagnosis and management of thyroid disorders in pregnancy and the postpartum period (2nd ed.) [J]. Chinese Journal of Perinatal Medicine, 2019, 22 (8): 505-506.
[13] Poppe K, Bisschop P, Fugazzola L, et al. 2021 European Thyroid Association Guideline on Thyroid Disorders before and during Assisted Reproduction [J]. Eur Thyroid J, 2020, 9 (6): 281-295.
[14] Fröhlich E, Wahl R. Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases [J]. Frontiers in Immunology, 2017, 8.
[15] Monteleone P, Parrini D, Faviana P, et al. Female Infertility Related to Thyroid Autoimmunity: The Ovarian Follicle Hypothesis [J]. Am J Reprod Immunol, 2011, 66 (2): 108-114.
[16] Cavallo IK, Cruz CD, Oliveira ML, et al. Angiotensin-(1-7) in human follicular fluid correlates with oocyte maturation [J]. Hum Reprod, 2017: 1.
[17] Cai YY, Lin N, Zhong LP, et al. Serum, and follicular fluid thyroid hormone levels and assisted reproductive technology outcomes [J]. Reprod Biol Endocrinol, 2019, 17 (1).
[18] Nikolic D, Medenica S, Garalejic E, et al. Follicular fluid thyroid autoantibodies, thyrotropin, free thyroxine levels and assisted reproductive technology outcome [J]. Plus One, 2018, 13 (10): e0206652.
[19] Parrini D, Casarosa E, Cela V, et al. Female infertility related to thyroid autoimmunity: the ovarian follicle hypothesis [J], 2013.
[20] Giacobbe M, Conti M, Gomes A, et al. Effectivity of conventional in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) when the malefactor is absent: a perspective point of view [J]. JABRA Assisted Reproduction, 2021.
[21] Yeste M, Jones C, Amdani SN, et al. Oocyte activation deficiency: A role for an oocyte contribution? [J]. Hum Reprod Update, 2015, 22 (1).
[22] Abu-Hassan D, Al-Hasani S. The use of ICSI for all cases of in-vitro conception [J]. Hum Reprod, 2003, 18 (4): 893-4; author reply 894-5.
[23] B VQ, Lan N, Tml A, et al. Intracytoplasmic sperm injection versus conventional in-vitro fertilization in couples with infertility in whom the male partner has normal total sperm count and motility: an open-label, randomized controlled trial [J]. Lancet, 2021, 397 (10284): 1554-1563.
[24] Song J, Liao T, Fu K, et al. ICSI Does Not Improve Live Birth Rates but Yields Higher Cancellation Rates Than Conventional IVF in Unexplained Infertility [J]. Front Medic, 2021, 7.
[25] N, V, Bachmakova, et al. The development of ovarian hyperstimulation syndrome in the implementation of assisted reproductive technology in women with a background of endocrine pathology [J]. Gynecol Endocrinol, 2014.
[26] Yang Yuan. Effect of thyroid autoantibodies on the outcome of in vitro fertilization-embryo transfer in women with normal thyroid function [D]. Shanxi Medical University, 2021.
[27] Kelkar RL, Meherji PK, Kadam SS, et al. Circulating autoantibodies against the zona pellucida and thyroid microsomal antigen in women with premature ovarian failure [J]. J Reprod Immunol, 2005, 66 (1): 53-67.
[28] Karim T, Nathalie L, Anne-Claire T, et al. The risk for four specific congenital heart defects associated with assisted reproductive techniques: a population-based evaluation [J]. Hum Reprod, 2013, (2): 367-374.
[29] Davies M, Rumbold A, Marino J, et al. Maternal factors and the risk of birth defects after IVF and ICSI: a whole of population cohort study [J]. BJOG, 2017, 124 (10): 1537-1544.
[30] Shao SHA, Jiang ME, Ding T, et al. Progress in the study of the effect of intracytoplasmic single sperm injection on the safety of offspring [J]. Journal of Reproductive Medicine, 2021, 30 (10): 1393-1397.
[31] Ag, Sutcliffe, Taylor, et al. Outcome in the second year of life after in-vitro fertilization by intracytoplasmic sperm injection: a UK case-control study [J]. Lancet, 2001.
[32] Sauerbrun-Cutler M-T, Huber W J, Has P, et al. Is intracytoplasmic sperm (ICSI) better than traditional in vitro fertilization (IVF): confirmation of higher blastocyst rates per oocyte using a split insemination design [J]. J Assist Reprod Gen, 2020, 37 (7): 1661-1667.
Cite This Article
  • APA Style

    Kang Yi-fan, Gao Qing-zhuo, Yin Zhao-fang, Wang Zhi-hong, Liang Hui-zhi, et al. (2023). Comparison of Pregnancy Outcomes in Thyroid Antibody-Positive Women with Different Fertilization Methods. Biomedical Sciences, 9(2), 35-41. https://doi.org/10.11648/j.bs.20230902.11

    Copy | Download

    ACS Style

    Kang Yi-fan; Gao Qing-zhuo; Yin Zhao-fang; Wang Zhi-hong; Liang Hui-zhi, et al. Comparison of Pregnancy Outcomes in Thyroid Antibody-Positive Women with Different Fertilization Methods. Biomed. Sci. 2023, 9(2), 35-41. doi: 10.11648/j.bs.20230902.11

    Copy | Download

    AMA Style

    Kang Yi-fan, Gao Qing-zhuo, Yin Zhao-fang, Wang Zhi-hong, Liang Hui-zhi, et al. Comparison of Pregnancy Outcomes in Thyroid Antibody-Positive Women with Different Fertilization Methods. Biomed Sci. 2023;9(2):35-41. doi: 10.11648/j.bs.20230902.11

    Copy | Download

  • @article{10.11648/j.bs.20230902.11,
      author = {Kang Yi-fan and Gao Qing-zhuo and Yin Zhao-fang and Wang Zhi-hong and Liang Hui-zhi and Yang Yuan and Yang Pan and Duan Xia},
      title = {Comparison of Pregnancy Outcomes in Thyroid Antibody-Positive Women with Different Fertilization Methods},
      journal = {Biomedical Sciences},
      volume = {9},
      number = {2},
      pages = {35-41},
      doi = {10.11648/j.bs.20230902.11},
      url = {https://doi.org/10.11648/j.bs.20230902.11},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.bs.20230902.11},
      abstract = {Objective To compare the pregnancy outcomes of thyroid antibody (ATA) positive women treated by different fertilization methods during in vitro fertilization-embryo transfer. Methods A total of 204 female patients with normal thyroid function and positive ATA in the reproductive Medicine Center of the First Hospital of Shanxi Medical University from January 2020 to January 2022 were selected. According to different fertilization methods, they were divided into IVF group and ICSI group, including 115 IVF cycles and 89 ICSI cycles. The general data, clinical indicators after ovulation induction, fertilization, embryo status, and pregnancy outcome of the two groups were compared. Results There were no significant differences in age, BMI, bE2, FSH, FT3, FT4, AFC, Gn dosage, Gn stimulation time, E2 on HCG day, P on HCG day, intrauterine thickness on HCG day, number of retrieved oocytes and average number of embryos transferred between the two groups (P>0.05). The fertilization rate of the ICSI group was higher than that of IVF group within the group, while the high-quality embryo rate was significantly lower than that of the IVF group, with statistical significance (P0.05). There were no significant differences in embryo implantation rate, biochemical pregnancy rate, clinical pregnancy rate, early abortion rate and live birth rate between the two groups (P>0.05). Logistic regression analysis showed that the method of assisted pregnancy and semen quality were not independent factors affecting high-quality embryo (P>0.05). In IVF group, TGAb was negatively correlated with fertilization rate (r=-0.202, PConclusion Thyroid autoimmunity (TAI) in infertile women undergoing assisted reproductive technology (ART), the semen quality should be considered as the priority criteria for ATA. ICSI should not be recommended as routine fertilization.},
     year = {2023}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Comparison of Pregnancy Outcomes in Thyroid Antibody-Positive Women with Different Fertilization Methods
    AU  - Kang Yi-fan
    AU  - Gao Qing-zhuo
    AU  - Yin Zhao-fang
    AU  - Wang Zhi-hong
    AU  - Liang Hui-zhi
    AU  - Yang Yuan
    AU  - Yang Pan
    AU  - Duan Xia
    Y1  - 2023/04/11
    PY  - 2023
    N1  - https://doi.org/10.11648/j.bs.20230902.11
    DO  - 10.11648/j.bs.20230902.11
    T2  - Biomedical Sciences
    JF  - Biomedical Sciences
    JO  - Biomedical Sciences
    SP  - 35
    EP  - 41
    PB  - Science Publishing Group
    SN  - 2575-3932
    UR  - https://doi.org/10.11648/j.bs.20230902.11
    AB  - Objective To compare the pregnancy outcomes of thyroid antibody (ATA) positive women treated by different fertilization methods during in vitro fertilization-embryo transfer. Methods A total of 204 female patients with normal thyroid function and positive ATA in the reproductive Medicine Center of the First Hospital of Shanxi Medical University from January 2020 to January 2022 were selected. According to different fertilization methods, they were divided into IVF group and ICSI group, including 115 IVF cycles and 89 ICSI cycles. The general data, clinical indicators after ovulation induction, fertilization, embryo status, and pregnancy outcome of the two groups were compared. Results There were no significant differences in age, BMI, bE2, FSH, FT3, FT4, AFC, Gn dosage, Gn stimulation time, E2 on HCG day, P on HCG day, intrauterine thickness on HCG day, number of retrieved oocytes and average number of embryos transferred between the two groups (P>0.05). The fertilization rate of the ICSI group was higher than that of IVF group within the group, while the high-quality embryo rate was significantly lower than that of the IVF group, with statistical significance (P0.05). There were no significant differences in embryo implantation rate, biochemical pregnancy rate, clinical pregnancy rate, early abortion rate and live birth rate between the two groups (P>0.05). Logistic regression analysis showed that the method of assisted pregnancy and semen quality were not independent factors affecting high-quality embryo (P>0.05). In IVF group, TGAb was negatively correlated with fertilization rate (r=-0.202, PConclusion Thyroid autoimmunity (TAI) in infertile women undergoing assisted reproductive technology (ART), the semen quality should be considered as the priority criteria for ATA. ICSI should not be recommended as routine fertilization.
    VL  - 9
    IS  - 2
    ER  - 

    Copy | Download

Author Information
  • Department of Reproductive Center, The First Hospital of Shanxi Medical University, Taiyuan, China

  • Department of Reproductive Center, The First Hospital of Shanxi Medical University, Taiyuan, China

  • Department of Reproductive Center, The First Hospital of Shanxi Medical University, Taiyuan, China

  • Department of Reproductive Center, The First Hospital of Shanxi Medical University, Taiyuan, China

  • Department of Reproductive Center, The First Hospital of Shanxi Medical University, Taiyuan, China

  • Department of Reproductive Center, The First Hospital of Shanxi Medical University, Taiyuan, China

  • Department of Reproductive Center, The First Hospital of Shanxi Medical University, Taiyuan, China

  • Department of Reproductive Center, The First Hospital of Shanxi Medical University, Taiyuan, China

  • Sections